shortagewatch

Home / Digestive tract and metabolism / Tirzepatide

ATC A10BX16 · Other Blood Glucose Lowering Drugs, excl. Insulins

Tirzepatide shortage

As of 2 Nov 2026, Tirzepatide has a reported shortage in 1 of the 15 countries we track (Canada), covering 6 products from 1 company.

Countries1/15
Products6packs or presentations
Companies11 listed
Short since22 Jan 202521 months ago
Earliest returnnot givencompany estimate
Main reasonOther

Timeline

Canada
20262027MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)MOUNJARO (3 mL single-dose vial)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Eli Lilly6 LLY

Listed: Eli Lilly LLY · NYSE

Compared with similar medicines

ATC group A10BX · Other Blood Glucose Lowering Drugs, excl. Insulins
Repaglinide5/15Tirzepatide1/15

Affected products

CountryProductCompanySinceExpected backReason
CAMOUNJARO (3 mL single-dose vial) limitedELI LILLY CANADA INC22 Jan 2025not givenOther
Other (Please describe in comments)
CAMOUNJARO (3 mL single-dose vial) limitedELI LILLY CANADA INC5 Mar 2025not givenOther
Other (Please describe in comments)
CAMOUNJARO (3 mL single-dose vial) limitedELI LILLY CANADA INC17 Mar 2025not givenOther
Other (Please describe in comments)
CAMOUNJARO (3 mL single-dose vial) limitedELI LILLY CANADA INC3 Apr 2025not givenOther
Other (Please describe in comments)
CAMOUNJARO (3 mL single-dose vial) limitedELI LILLY CANADA INC1 Oct 2025not givenOther
Other (Please describe in comments)
CAMOUNJARO (3 mL single-dose vial) limitedELI LILLY CANADA INC1 Oct 2025not givenOther
Other (Please describe in comments)

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.